Hoth Therapeutics, Inc. — Director's Dealing 2019

Mar 7, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2019-03-06

Reporting Person: Briones David S. (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-06	Options	$5.88	J	50000	Acquired	2024-03-06	Common Stock (50000)	Direct

Footnotes

F1: The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan and vested in full upon grant.